Renovion
First Patient Enrolled in Phase 2 Clinical Study Evaluating ARINA-1 for the Treatment of NCFBE
Renovion and COPD Foundation Joint Release – Renovion, Inc. has announced that the first patient has been enrolled in a Phase 2 clinical...
Search
Renovion
- 2 min
Renovion Receives Notice of Study May Proceed Status for Lung Transplant Program
Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for serious chronic inflammatory lung diseases...
Renovion
- 3 min
Marty Zamora, MD, joins Renovion, Inc. as Chief Medical Officer
Renovion today announced that Dr. Martin “Marty” Zamora, MD, has joined Renovion as Chief Medical Officer. Dr. Zamora will lead the Phase...
Renovion
- 2 min
Renovion Provides Regulatory Update and Initiation of Clinical Program in Non-CF Bronchiectasis
Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for rare, chronic, and serious lung diseases...
Renovion
- 6 min
A breathe-easier breakthrough
Renovion, a UNC-affiliated startup, advances a breakthrough therapy to restore lung health and quality of life in patients with diseases...
Renovion
- 3 min
Exploristics signs collaboration agreement with Renovion, using the cloud-based simulation platform
Exploristics is pleased to announce today a collaboration with Renovion using Exploristics’ innovative study simulation software platform...
Renovion
- 3 min
Renovion and the COPD Foundation Launch COPD and Bronchiectasis Development Partnership
Renovion and the COPD Foundation have announced the creation of a new partnership to accelerate the development of a novel therapy for...
Renovion
- 2 min
Renovion Announces Addition of Rich Mattingly to Board of Directors
Renovion, Inc., a biopharmaceutical company on a mission to transform the treatment of chronic inflammatory lung diseases, announced the...
Renovion
- 2 min
Publication of Research Demonstrating the Impact of ARINA-1 on Mucus Transport in Cystic Fibrosis
Renovion, Inc., a biopharmaceutical company on a mission to transform the lives of patients with chronic lung diseases characterized by...
Renovion
- 3 min
Completion of $8.1 Million Financing Round Enabling Clinical Programs in Chronic Lung Diseases
Poised for pivotal lung transplant trial in U.S. Renovion, Inc., a biopharmaceutical company on a mission to transform the treatment of...
Renovion
- 2 min
Dr. Robert Ryan joins Renovion, Inc. Board of Directors
Renovion, Inc., a privately-held biopharmaceutical company developing novel therapeutics for respiratory diseases, including lung...
Renovion
- 2 min
Renovion Elects Derek Winstanly as Chairman of Board of Directors
Renovion, Inc. ("Renovion"), an early stage drug development company targeting a novel treatment for lung transplant patients and other...
Renovion
- 2 min
Renovion Receives Orphan Designation for ARINA-1 for the treatment of Lung Dysfunction
Renovion, Inc. ("Renovion"), an early stage drug development company targeting the treatment of lung transplant and other chronic...
Renovion
- 2 min
Chapel Hill startups represent in D.C.
Two Chapel Hill-based startups — EpiCypher and Renovion — attended the first University Startups Demo Day in Washington, D.C. On Tuesday,...
Renovion
- 3 min
‘Spirit of Innovation’
Of the more than 800 startups created at universities across the country this year, only 35 have been handpicked as the best and earned...
Renovion
- 2 min
Entrepreneur with GSK roots targets lung transplant survival rates with UNC technology
In a tiny lab in Chapel Hill, a 3-year-old startup with UNC-Chapel Hill technology is trying to help lung transplant patients defy the...
Renovion
- 2 min
Renovion Receives Patent Allowance for Novel Therapy
- Patent claims set foundation for commercialization - Board and management team in place to execute pre-clinical plan CHAPEL HILL, N.C.,...